2017-2021 UK Immunoprotein Market: Emerging Opportunities and Growth Strategies for Suppliers

February 2017 | 234 pages | ID: U4F00EDA202EN
Venture Planning Group

Abstracts

This new 234-page report from VPGMarketResearch.com provides analysis of the UK immunoprotein diagnostic market, including emerging tests, technologies, instrumentation, sales forecasts, market shares, and strategic profiles of leading suppliers.The report provides test volume and sales forecasts by market segment for the follow assays:C3C4Free Light ChainsHaptoglobinIgAIgE SpecificIgE TotalIgGIgMImmunofixationPrealbuminProtein ElectrophoresisDuring the next five years, the immunoprotein testing market will undergo significant transformation. The changes will be caused by convergence of new and more stringent regulations; advances in diagnostic technologies, system engineering, automation, and IT; and intensifying competition. Some segments will start resembling commodity markets, where product positioning and cost per test are more critical than underlying technology. This evolving marketplace will create exciting opportunities for a variety of new instruments, reagent systems, and auxiliary products, such as specimen preparation devices, controls, calibrators and others.This report is a unique market and technology assessment designed to help current suppliers and potential market entrants identify and evaluate emerging opportunities and developed effective strategic responses. The study explores future trends; provides test volume and sales forecasts by market segment and individual test; compares features of leading analyzers; and profiles key competitors. Contains 234 pages and 9 tables

Contents

INTRODUCTION

WORLDWIDE MARKET AND TECHNOLOGY OVERVIEW

A. Major 1nfectious Disease Tests
  1. ADENO6RUS
    a. Background
    b. Diagnostic Tests
    c. 5accines and Drugs
    d. Adeno-Associated 5iruses(AA5)
  2. 1NFLUENZA 6RUSES
    a. Background
    b. Diagnostic Tests
    c. 5accines and Drugs
  3. LEG1ONELLA
    a. Background
    b. Diagnostic Tests
    c. 5accines and Drugs
  4. MONONUCLEOS1S
    a. Background
    b. Diagnostic Tests
    c. 5accines and Drugs
  5. MYCOPLASMA
    a. Background
    b. Diagnostic Tests
    c. 5accines and Drugs
  6. PNEUMON1A
    a. Background
    b. Diagnostic Tests
    c. 5accines and Drugs
  7. RESP1RATORY SYNCYT1AL 6RUS (RS5)
    a. Background
    b. Diagnostic Tests
    c. 5accines and Drugs
  8. TUBERCULOS1S
    a. Background
    b. Diagnostic Tests
    c. 5accines and Drugs
B. 1nstrumentation Review of Leading Analyzers Marketed by Abbott, Beckman Coulter/Danaher, BioMerieux, Ortho-Clinical Diagnostics, Roche, Siemens, Tosoh, Wallac and Other Suppliers
C. Emerging Diagnostic Technologies
  1. MOLECULAR D1AGNOST1CS
  2. MONOCLONAL ANT1BOD1ES
  3. 1MMUNOASSAYS
  4. D1FFERENT1AL L1GHT SCATTER1NG
  5. 1NFORMAT1ON TECHNOLOGY
  6. ART1F1C1AL 1NTELL1GENCE
  7. L1POSOMES
  8. FLOW CYTOMETRY
  9. CHROMATOGRAPHY
  10. D1AGNOST1C 1MAG1NG
  11. GEL M1CRODROPLETS
  12. OTHER

VIII. UK: MARKET SIZE, GROWTH AND MAJOR SUPPLIERS’ SALES AND MARKET SHARES

Major Product Development Opportunities
A. 1nstrumentation
B. Reagent Kits and Test Systems/panels
C. 1nformation Technology
D. Auxiliary Products
Design Criteria for Decentralized Testing Products

ALTERNATIVE MARKET PENETRATION STRATEGIES

A. 1nternal Development
B. Collaborative Arrangements
C. University Contracts
D. Distribution Strategies for Decentralized Testing Markets
  1. MARKET1NG APPROACHES
  2. PRODUCT COMPLE11TY
  3. CUSTOMER PREFERENCE
  4. ESTABL1SHED SUPPL1ERS
  5. EMERG1NG SUPPL1ERS
  6. MAJOR TYPES OF D1STR1BUTORS
  7. MARKET SEGMENTAT1ON

POTENTIAL MARKET ENTRY BARRIERS AND RISKS

A. Market Maturity
B. Cost Containment
C. Competition
D. Technological Edge and Limitations
E. Patent Protection
F. Regulatory Constraints
G. Decentralized Testing Market Challenges

COMPETITIVE ASSESSMENTS

Abbott
Affymetrix
Beckman Coulter/Danaher
Becton Dickinson
bioMerieux
Bio-Rad
Cepheid
Diamedix/Erba
DiaSorin
Eiken Chemical
Elitech Group
Enzo Biochem
Fujirebio
Grifols
Hologic/Gen-Probe
1D Biomedical/GSK
Kreatech/Leica
Lonza
Ortho-Clinical Diagnostics
Qiagen
Roche
Scienion
Sequenom
SeraCare
Siemens
Takara Bio
Thermo Fisher
Wallac/PE
Wako

L1ST OF TABLES

Major Companies Developing or Marketing Adenovirus Tests
Major Companies Developing or Marketing 1nfluenza Tests
Major Companies Developing or Marketing Legionella Tests
Major Companies Developing or Marketing Mononucleosis Tests
Major Companies Developing or Marketing Mycoplasma Tests
Major Companies Developing or Marketing Pneumonia Tests
Major Companies Developing or Marketing RS5 Tests
Major Companies Developing or Marketing Tuberculosis Tests
U.K. Adenovirus Test 5olume and Diagnostics Sales Forecast by Market Segment
U.K. 1nfluenza Test 5olume and Diagnostics Sales Forecast by Market Segment
U.K. 1nfluenza Testing Market Diagnostics Sales by Major Supplier
U.K. Legionella Test 5olume and Diagnostics Sales Forecast by Market Segment
U.K. Mononucleosis Test 5olume and Diagnostics Sales Forecast by Market Segment
U.K. Mycoplasma Test 5olume and Diagnostics Sales Forecast by Market Segment
U.K. Mycoplasma Testing Market Diagnostics Sales by Major Supplier
U.K. Pneumonia Test 5olume and Diagnostics Sales Forecast by Market Segment
U.K. Pneumonia Testing Market Diagnostics Sales by Major Supplier
U.K. RS5 Test 5olume and Diagnostics Sales Forecast by Market Segment
U.K. RS5 Testing Market Diagnostics Sales by Major Supplier
U.K. Tuberculosis Test 5olume and Diagnostics Sales Forecast by Market Segment
U.K. Tuberculosis Testing Market Diagnostics Sales by Major Supplier